Stage-Specific Degradation of Cyclin D3 Orchestrates Myelopoiesis and Restrains Myeloproliferative Neoplasm Development.

Stage-specific degradation of cyclin D3 prevents myeloproliferative neoplasms by regulating myelopoiesis, with sustained levels causing MPN development in mice.

• Why it matters: Understanding how cyclin D3 controls blood cell development is crucial because its mutations are linked to lymphoid cancers and uncontrolled proliferation can lead to serious blood disorders.
• What they did: Researchers created a mouse model with a degradation-resistant cyclin D3 (D3T283A) to study its effects, revealing increased granulocyte-monocyte differentiation, altered blood cell outputs, and MPN development.
• The result: Persistent cyclin D3 levels promoted self-renewal of hematopoietic stem cells and drove myeloproliferation, which could be mitigated by targeting FOXM1 and PRMT5 pathways, offering potential therapeutic targets.